Aspire Biopharma Holdings, Inc. (ASBP) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-19 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-08-10 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-07-20 | 8-K | Other Events | SEC |
| 2026-06-22 | 8-K | Shareholder Vote Results | SEC |
| 2026-06-12 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-06-12 | 8-K | Other Events | SEC |
| 2026-05-14 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2026-04-20 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-04-16 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-04-16 | 8-K | Shareholder Vote Results | SEC |
| 2026-04-16 | 8-K | Material Agreement, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2026-04-15 | 8-K | Material Agreement | SEC |
| 2026-02-12 | 8-K | Material Agreement, Unregistered Sales, Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-02-06 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2026-01-30 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2026-01-15 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-01-13 | 8-K | Officer / Director Changes | SEC |
| 2026-01-06 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-11-14 | 8-K | Material Agreement, Termination of Agreement, Direct Financial Obligation, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-11-05 | 8-K | Shareholder Vote Results | SEC |
| 2025-10-17 | 8-K | Listing Notice, Financial Statements & Exhibits | SEC |
| 2025-09-26 | 8-K | Unregistered Sales, Auditor Change, Financial Statements & Exhibits | SEC |
| 2025-08-22 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-07-30 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-06-18 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-06-10 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-04-30 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-04-18 | 8-K | Listing Notice, Financial Statements & Exhibits | SEC |
| 2025-02-21 | 8-K | Material Agreement, Acquisition or Disposition, Direct Financial Obligation, Unregistered Sales, Item 3.03, Auditor Change, Change in Control, Officer / Director Changes, Charter Amendments, Item 5.05, Item 5.06, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-02-20 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-02-10 | 8-K | Shareholder Vote Results, Other Events, Financial Statements & Exhibits | SEC |
| 2024-12-26 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-10-10 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-10-04 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-09-06 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-09-03 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-30 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-07-23 | 8-K | Termination of Agreement, Financial Statements & Exhibits | SEC |
| 2024-06-07 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-05-28 | 8-K | Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-05-22 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-05-20 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-05-16 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.